According to the Pathology Atlas of the Human Cancer Transcriptome high mRNA expression of HGF or CDK4 in urothelial bladder cancer correlates with a worse overall survival compared to patients with low expression of these genes (P-scores: HGF 0.021 and CDK4 0.016) [29]. The gene discussed is HGF; the disease is bladder transitional cell carcinoma.